WHA 0.00% 48.7¢ wattle health australia limited

SAMR/CFDA Approval Processing, page-37

  1. 26,847 Posts.
    lightbulb Created with Sketch. 1841
    Bear in mind, the 1-2 years timeframe was estimated by the agent, not the official timeframe.

    a2 Milk submitted CFDA application in May 2017, received CFDA approval within FIVE months on 28 September 2017.
    1.png



    Here's official procedure for SAMR/CFDA approval:




    Source: China CFDA Finalizes Infant Formula Registration Rules, By Erex Chen, Mylink Law Office




    On 6 April 2018, ASX announcement:

    CFDA Update

    Further to the announcement on 20 November 2017, WHA can confirm it has submitted all
    supplementary documentation requested by CFDA, in February 2018. WHA’s consultants in China
    have confirmed no further requests for information have been made by CFDA and WHA’s application
    is on track for final accreditation.




    On 27 July 2018, ASX announcement:

    Further to our announcement of 6 April 2018, WHA has passed technical evaluation for State Administration for Market Regulation (SAMR, formerly known as CFDA) accreditation for China. WHA is now waiting for formal approval and attainment of SAMR, on receipt of which revenue is projected to reach in excess of $140 million over a 42-month period in the China market.
    Cash at bank at the end of the quarter was around $50 million with nil debt.


    Since the first CFDA approval released on 4 August 2017, most applications were approved in about 5 months.
    However, it takes a bit longer due to Chinese new year and restructure of the CFDA to SAMR.
    I think the SAMR approval should be around the corner.
 
watchlist Created with Sketch. Add WHA (ASX) to my watchlist

Currently unlisted public company.

arrow-down-2 Created with Sketch. arrow-down-2 Created with Sketch.